Stock listing
NASDAQ:AKRO Akero Therapeutics Inc Stock
Follow Akero Therapeutics Inc into a list and get an email when it puts out news.
Last close · NASDAQ:AKRO
$54.65 USD
Close on Dec 9, 2025 · No longer trades
- Lowest – highest close
- $8.00 – $57.56 USDSince Jun 20, 2019 · lowest Jun 1, 2022 · highest Feb 5, 2025
Delisted NASDAQ:AKRO no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:AKRO
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Akero Therapeutics Inc on 6ix
- Decks
- 16 decks · latest Jan 27, 2025
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (January 2025) | Investor deck | 71 slides | Jan 27, 2025 |
| Technical Presentation (January 2025) | Technical | 22 slides | Jan 27, 2025 |
| Technical Presentation (March 2024) | Technical | 23 slides | Mar 4, 2024 |
| Technical Presentation (October 2023) | Technical | 25 slides | Oct 10, 2023 |
| Investor Presentation (June 2023) | Investor deck | 64 slides | Jun 5, 2023 |
| Technical Presentation (September 2022) | Technical | 21 slides | Sep 13, 2022 |
| Investor Presentation (June 2022) | Investor deck | 45 slides | Jun 8, 2022 |
| Investor Presentation (September 2021) | Investor deck | 40 slides | Sep 9, 2021 |
| Investor Presentation (May 2021) | Investor deck | 46 slides | May 13, 2021 |
| Investor Presentation (April 2021) | Investor deck | 46 slides | Apr 13, 2021 |
All 16 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| JP Morgan Healthcare Conference 2021 | Conference | 33 slides | Jan 11, 2021 |
| Investor Presentation (November 2020) | Investor deck | 32 slides | Nov 16, 2020 |
| Technical Presentation (June 2020) | Technical | 21 slides | Jun 30, 2020 |
| Corporate Update (March 2020) | Corporate update | 10 slides | Mar 31, 2020 |
| Investor Presentation (January 2020) | Investor deck | 19 slides | Jan 13, 2020 |
| Investor Presentation (September 2019) | Investor deck | 19 slides | Sep 6, 2019 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Jane Pritchett Henderson Other companies: CARGO Therapeutics, Inc. (Director · Since at least Jun 3, 2024); Apogee Therapeutics, Inc. (Chief Financial Officer · Since at least Jul 13, 2023); Invivyd, Inc. (Chief Financial Officer · Aug 5, 2021 – Jan 30, 2022 · Past); Sesen Bio Inc (Director · Jun 12, 2018 – May 3, 2021 · Past); IVERIC bio Inc (Director · Jan 13, 2018 – Jul 11, 2023 · Past); Voyager Therapeutics, Inc. (Sr. V.P. & CFO, Corp. Dev. · Jan 1, 2017 – Mar 22, 2018 · Past); Eleven Biotherapeutics Inc (Director · Feb 5, 2014 – May 19, 2017 · Past) | Director · Since at least Jun 19, 2019 |
| Mark Iwicki Other companies: Inhibikase Therapeutics, Inc. (Chief Executive Officer - Inhibikase · Since at least Feb 14, 2025); Q32 Bio Inc. (Director · Since at least Mar 25, 2024); Third Harmonic Bio Inc. (Director · Since at least Sep 14, 2022); Kala Bio, Inc. (Director · Since at least Jul 19, 2017); Jade Biosciences, Inc. (Director · Apr 2, 2021 – Jun 5, 2024 · Past); Pulmatrix, Inc. (Director · Mar 20, 2017 – Jan 28, 2021 · Past); Aimmune Therapeutics Inc (Director · May 25, 2016 – Oct 10, 2020 · Past) | Director · Since at least Jun 19, 2019 |
| Tomas J. Heyman Other companies: Legend Biotech Corp. (Director · Since at least Mar 18, 2026); Exelixis, Inc. (Director · Since at least May 31, 2023); Xilio Therapeutics, Inc. (Director · Sep 15, 2022 – Jun 12, 2023 · Past); Invivyd, Inc. (Director · Aug 5, 2021 – May 23, 2023 · Past); OptiNose (Director · Dec 1, 2020 – May 21, 2025 · Past) | Director · Since at least Jun 9, 2020 |
| Aaron E. Royston Other companies: Attovia Therapeutics, Inc. (Director · Since at least Aug 4, 2026); Achieve Life Sciences, Inc. (Director · Since at least Apr 16, 2026); RayzeBio, Inc. (Director · Sep 14, 2023 – Sep 14, 2023 · Past); Ventyx Biosciences Inc (Director · Oct 20, 2021 – Jun 9, 2022 · Past) | Director · Jun 19, 2019 – Jun 24, 2019 · Past |
| Andrew Cheng Other companies: Damora Therapeutics, Inc. (Board Director · Since at least Aug 10, 2026); TCGX Acquisition Corp. (Director · Since at least Aug 4, 2026); Vera Therapeutics, Inc. (Director · Since at least May 13, 2021); Arbutus Biopharma Corporation (Director · Aug 17, 2019 – Jun 3, 2021 · Past) | President and CEO, Director · Since at least Jun 19, 2019 |
| Seth L. Harrison Other companies: Stoke Therapeutics, Inc. (Director · Since at least Jun 18, 2019); Avalo Therapeutics, Inc. (Director · Oct 14, 2015 – Oct 20, 2015 · Past); Eledon Pharmaceuticals, Inc. (Director · Sep 16, 2014 – Jun 15, 2016 · Past); HeartWare International Inc (Director · Jun 28, 2007 – Aug 23, 2016 · Past) | Director · Since at least Jun 19, 2019 |
| G Walmsley Graham Other companies: Olema Pharmaceuticals, Inc. (Director · Since at least Jun 1, 2020); LifeSci Acquisition II Corp (Director · Nov 20, 2020 – Nov 20, 2020 · Past); ALX Oncology Holdings Inc. (Director · Jul 16, 2020 – Jun 11, 2021 · Past) | Director · Since at least Jun 19, 2019 |
| Kevin Bitterman Other companies: Disc Medicine, Inc. (Director · Since at least Dec 29, 2022); Editas Medicine, Inc. (Director · Feb 2, 2016 – Jun 15, 2017 · Past) | Director · Jun 19, 2019 – Jun 1, 2021 · Past |
| William Richard White Other companies: Disc Medicine, Inc. (Director · Since at least Dec 29, 2022); Ventyx Biosciences Inc (Director · Since at least Oct 20, 2021) | Chief Financial Officer · Since at least Jun 19, 2019 |
| Yuan Xu Other companies: Xilio Therapeutics, Inc. (Board Member · Since at least Jan 4, 2022); Fate Therapeutics, Inc. (Board Member · Since at least Aug 3, 2021) | Director · Since at least Apr 22, 2021 |
All 16 people
| Person | Seat |
|---|---|
| Catriona Yale | Chief Development Officer · Since at least Jun 19, 2019 |
| Chou Judy | Director · Since at least Jul 12, 2021 |
| Jonathan Young | Chief Operating Officer · Since at least Jun 19, 2019 |
| Patrick Lamy | See Remarks · Since at least Jan 10, 2023 |
| Scott A Gangloff | Chief Technology Officer · Since at least Apr 29, 2024 |
| Timothy Rolph | Chief Scientific Officer · Since at least Jun 19, 2019 |
Log in to ask 6ix AI your own questions about Akero Therapeutics Inc.